Search results for "cognitive impairment"

showing 10 items of 221 documents

Changes in Speech Range Profile Are Associated with Cognitive Impairment

2021

Background and Purpose The aim of this study was to describe the variations in the speech range profile (SRP) of patients affected by cognitive decline. Methods We collected the data of patients managed for suspected voice and speech disorders, and suspected cognitive impairment. Patients underwent an Ear Nose and Throat evaluation and Mini-Mental State Examination (MMSE). To obtain SRP, we asked the patients to read 18 sentences twice, at their most comfortable pitch and loudness as they would do in daily conversation, and recorded their voice on to computer software. Results The study included 61 patients. The relationship between the MMSE score and SRP parameters was established. Increas…

Cognitive Impairmentmedicine.medical_specialtyRange (music)business.industryEar nose and throatCognitionAudiologymedicine.diseaseMental Status and Dementia Testsenvironment and public healthLoudnessComputer softwareotorhinolaryngologic diseasesMedicineDementiaSpeechOriginal ArticleDementiaCognitive declinebusinessCognitive impairmentLanguageDementia and Neurocognitive Disorders
researchProduct

P1‐107: Positive effects of a 6‐month stage‐specific cognitive intervention program on brain metabolism in subjects with amnestic mild cognitive impa…

2009

Cognitive Interventionmedicine.medical_specialtyEpidemiologybusiness.industryHealth PolicyDiseaseAudiologyPsychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeurosciencemedicineNeurology (clinical)Geriatrics and GerontologyStage specificCognitive impairmentbusinessAlzheimer's & Dementia
researchProduct

Cognitive impairment in relapsing-remitting multiple sclerosis can be predicted by imaging performed several years earlier.

2007

Cognitive deficits in multiple sclerosis (MS) are common and correlate with contemporary MRI brain abnormalities, particularly atrophy, but the ability of imaging early in the disease to predict later cognitive impairment remains to be determined. Thirty relapsing—remitting MS patients recruited within three years of the onset of the disease, and in whom MRI had been performed at baseline and a year later, were assessed neuropsychologically five years later. Imaging parameters accounting for significant variance in cognitive performance were identified using multiple regressions, once confounding variables were controlled. Patients performed significantly worse than expected on tests of at…

Cognitive deficits in multiple sclerosisAdultMalePediatricsmedicine.medical_specialtyDevelopmental psychologyCentral nervous system diseaseDisability EvaluationAtrophyDegenerative diseaseMultiple Sclerosis Relapsing-Remittingrelapsing-remitting multiple sclerosiPredictive Value of TestsmedicineHumansMultiple sclerosiCognitive impairmentMultiple sclerosisCognitive disorderCognitionMiddle Agedmedicine.diseaseMagnetic Resonance ImagingEarly DiagnosisNeurologyRelapsing remittingLinear ModelsFemaleNeurology (clinical)AtrophyPsychologyCognition DisordersFollow-Up StudiesMultiple sclerosis (Houndmills, Basingstoke, England)
researchProduct

The Potential Role of miRNAs in Cognitive Frailty.

2021

Frailty is an aging related condition, which has been defined as a state of enhanced vulnerability to stressors, leading to a limited capacity to meet homeostatic demands. Cognitive impairment is also frequent in older people, often accompanying frailty. Age is the main independent risk factor for both frailty and cognitive impairment, and compelling evidence suggests that similar age-associated mechanisms could underlie both clinical conditions. Accordingly, it has been suggested that frailty and cognitive impairment share common pathways, and some authors proposed “cognitive frailty” as a single complex phenotype. Nevertheless, so far, no clear common underlying pathways have been discove…

Cognitive frailtyAgingbiomarkers cognitive frailty cognitive impairment frailty MCI (mild cognitive impairment) miRNA–microRNACognitive NeuroscienceVulnerabilitycognitive frailtyNeurosciences. Biological psychiatry. NeuropsychiatryReviewfrailtyMCI (mild cognitive impairment)MCI (mild cognitive impairment); biomarkers; cognitive frailty; cognitive impairment; frailty; miRNA–microRNAmicroRNAMedicinePathologicalcognitive impairmentbusiness.industryStressorbiomarkers; cognitive frailty; cognitive impairment; frailty; MCI (mild cognitive impairment); miRNA–microRNAbiomarkersCognitionPhenotypemiRNA–microRNAPotential biomarkersbiomarkerbusinessNeuroscienceRC321-571NeuroscienceFrontiers in aging neuroscience
researchProduct

The Mini Mental State Examination (MMSE) for Cognitive Impairment in multiple sclerosis (ms): a two years Longitudinal study in 300 patients.

2008

Cognitive impairment multiple sclerosis longitudinal studySettore MED/26 - Neurologia
researchProduct

Risk factors for cognitive impairment in subjects with Behçet's disease

2004

In the present study we evaluated the prevalence and risk factors for cognitive impairment in subjects with Behçet's Disease (BD). The following risk factors were studied: age, education, disease duration, activity of disease, prednisone dosage, and anxiety and depression levels. Twenty-six BD out-patients without overt neurological involvement and 26 sex-matched controls completed a comprehensive neuropsychological battery. Compared to controls, BD subjects were significantly impaired on tasks evaluating long-term verbal and nonverbal memory, and visuospatial skills. Cognitive impairment was evident in 46.1% of BD patients compared with none of control subjects (p<.0001), with memory repr…

Cognitive impairmentNeuropsychologyMedicine (all)CorticosteroidSettore MED/26 - NeurologiaDisease activityBehcet's disease
researchProduct

Biomarkers clinici, biologici, cognitivi e comportamentali per la malattia di Alzheimer ed il Mild Cognitive Impairment: dati di popolazione dello Za…

Nel 2015, quasi 47 milioni di persone in tutto il mondo sono state colpite da demenza, e si prevede che i valori raggiungeranno 75 milioni entro il 2030 e 131 milioni entro il 2050, con il maggiore aumento previsto nei paesi a basso e medio reddito. Nonostante gli enormi costi dell'assistenza medica e sociale per i pazienti affetti da AD dipendano dalla gravità della malattia, i dati sulla prevalenza della demenza sulla base della gravità o dello stadio sono carenti soprattutto nei contesti rurali e con basso livello di istruzione. L'obiettivo principale di questo studio è di valutare l'interazione tra fattori di rischio legati alla fragilità, le performance cognitive e i sintomi comportame…

Demenza Sindrome di Alzheimer Mild Cognitive Impairment Subjective Cognitive Decline prevalenza fattori associati
researchProduct

Cognitive Frailty: An Update

2021

This review article provides an update of the empirical research on cognitive fragility conducted in the last four years. The studies retrieved were classified in four different categories. The first category includes articles relating cognitive frailty to cognitive reserve and which continue to highlight the importance of educational level. The second category includes recent research on cognitive fragility biomarkers, involving neuroimaging, metabolism and, in a novel way, microbiota. The third category includes research on how cognitive frailty is related to motor development and physical functioning, exploring e.g. the use of technology to study motor markers of cognitive frailty. Final…

Dual-task interventionFrailtyPhysical activityMini Reviewmulticomponent intervention programsCognitive reserveMild cognitive impairmentbiomarkersphysical activityfrailtydual-task interventioncognitive reserveBF1-990mild cognitive impairmentSubjective cognitive declinePsychologyMulticomponent intervention programssubjective cognitive declineGeneral PsychologyBiomarkersFrontiers in Psychology
researchProduct

P4‐117: Low mood in late life and risk of amnestic versus other cognitive impairment with and without dementia: A longitudinal community‐based study

2008

EpidemiologyHealth Policymedicine.diseaseCommunity based studyPsychiatry and Mental healthCellular and Molecular NeuroscienceMoodDevelopmental NeurosciencemedicineDementiaNeurology (clinical)Geriatrics and GerontologyCognitive impairmentPsychologyClinical psychologyCognitive psychologyAlzheimer's &amp; Dementia
researchProduct

P2–182: Anxiety and depressive symptoms as predictors of progression from mild cognitive impairment to Alzheimer's disease

2006

Epidemiologybusiness.industryHealth PolicyDiseasePsychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeuroscienceMedicineAnxietyNeurology (clinical)Geriatrics and Gerontologymedicine.symptombusinessCognitive impairmentDepressive symptomsClinical psychologyAlzheimer's &amp; Dementia
researchProduct